Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy
- Conditions
- Congenital Myotonic Dystrophy
- Registration Number
- NCT07119775
- Lead Sponsor
- AMO Pharma Limited
- Brief Summary
This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method